Publication:
Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum

dc.contributor.authorSelina Boppen_US
dc.contributor.authorPamela Magistradoen_US
dc.contributor.authorWesley Wongen_US
dc.contributor.authorStephen F. Schaffneren_US
dc.contributor.authorAngana Mukherjeeen_US
dc.contributor.authorPharath Limen_US
dc.contributor.authorMehul Dhordaen_US
dc.contributor.authorChanaki Amaratungaen_US
dc.contributor.authorCharles J. Woodrowen_US
dc.contributor.authorElizabeth A. Ashleyen_US
dc.contributor.authorNicholas J. Whiteen_US
dc.contributor.authorArjen M. Dondorpen_US
dc.contributor.authorRick M. Fairhursten_US
dc.contributor.authorFrederic Arieyen_US
dc.contributor.authorDidier Menarden_US
dc.contributor.authorDyann F. Wirthen_US
dc.contributor.authorSarah K. Volkmanen_US
dc.contributor.otherHarvard School of Public Healthen_US
dc.contributor.otherUniversite Paris Descartesen_US
dc.contributor.otherUniversity of Oxforden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherCNRS Centre National de la Recherche Scientifiqueen_US
dc.contributor.otherNational Institutes of Health, Bethesdaen_US
dc.contributor.otherSimmons Collegeen_US
dc.contributor.otherInstitut Pasteur, Parisen_US
dc.contributor.otherBroad Instituteen_US
dc.contributor.otherInsermen_US
dc.contributor.otherMyanmar Oxford Clinical Research Uniten_US
dc.contributor.otherWorldwide Antimalarial Resistance Networken_US
dc.date.accessioned2019-08-23T10:25:28Z
dc.date.available2019-08-23T10:25:28Z
dc.date.issued2018-12-01en_US
dc.description.abstract© 2018 The Author(s). Multidrug resistant Plasmodium falciparum in Southeast Asia endangers regional malaria elimination and threatens to spread to other malaria endemic areas. Understanding mechanisms of piperaquine (PPQ) resistance is crucial for tracking its emergence and spread, and to develop effective strategies for overcoming it. Here we analyze a mechanism of PPQ resistance in Cambodian parasites. Isolates exhibit a bimodal dose-response curve when exposed to PPQ, with the area under the curve quantifying their survival in vitro. Increased copy number for plasmepsin II and plasmepsin III appears to explain enhanced survival when exposed to PPQ in most, but not all cases. A panel of isogenic subclones reinforces the importance of plasmepsin II-III copy number to enhanced PPQ survival. We conjecture that factors producing increased parasite survival under PPQ exposure in vitro may drive clinical PPQ failures in the field.en_US
dc.identifier.citationNature Communications. Vol.9, No.1 (2018)en_US
dc.identifier.doi10.1038/s41467-018-04104-zen_US
dc.identifier.issn20411723en_US
dc.identifier.other2-s2.0-85046402237en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/44990
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85046402237&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.subjectChemistryen_US
dc.subjectPhysics and Astronomyen_US
dc.titlePlasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparumen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85046402237&origin=inwarden_US

Files

Collections